Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

25.0%

2 terminated/withdrawn out of 8 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

75%

3 of 4 completed trials have results

Key Signals

1 recruiting3 with results

Enrollment Performance

Analytics

Phase 2
6(75.0%)
N/A
2(25.0%)
8Total
Phase 2(6)
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT06052254Phase 2Recruiting

Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type

Role: lead

NCT05412992Phase 2Terminated

Evaluation of the Dexmedetomidine Transdermal Systems for Postoperative Analgesia Following Abdominoplasty

Role: lead

NCT00916383Phase 2Completed

Study in Elderly Alzheimer's Patients to Assess Skin Tolerability, Irritation With 3, 7-Day Applications of DTP-System

Role: lead

NCT04242407Phase 2Unknown

Evaluating Efficacy of the Dexmedetomidine Transdermal System for Postoperative Analgesia Following Abdominoplasty

Role: lead

NCT02953054Phase 2Completed

Dexmedetomidine Transdermal System (DMTS) for Post-Operative Analgesia Following Bunionectomy

Role: lead

NCT00759330Phase 2Completed

Flurbiprofen Tape for Treatment of Chronic Low Back Pain

Role: lead

NCT00924508Not ApplicableTerminated

Hydrogel Patch for the Treatment of Eczema

Role: collaborator

NCT00234728Not ApplicableCompleted

Study of a New Dressing for Use With Topical Medications

Role: lead

All 8 trials loaded